Through the same molecular docking analysis piceatannol also has shown neuroprotective responses (Zhang et al., 2018; Talebi et al., 2020) with the potential of binding to ACE2, thereby playing a critical role in the prevention and treatment of COVID-19 (Wahedi et al., 2020; Ahmad et al., 2020). The gene discussed is ACE2; the disease is COVID-19.